Clinical Trials Browser

Rectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Urothelial Carcinoma of the Bladder

Colorectal Neoplasms

Carcinoma, Hepatocellular

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

GastroEsophageal Cancer

Small Bowel Adenocarcinoma

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Hepatocellular, Hepatoblastoma

Rectal Neoplasms

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Adenocarcinoma Of Esophagus

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Carcinoma, Pancreatic Neoplasms

Hepatoblastoma

Borderline Resectable Pancreatic Adenocarcinoma

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Head and Neck Neoplasms, Lung Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Liver Metastases From Colorectal Cancer (mCRC)

Breast Neoplasms

Oropharyngeal Neoplasms

Pancreatic Neoplasms, Neoplasms, Basal Cell

Keratosis, Actinic

Colorectal Neoplasms

Cervical Esophagus Adenocarcinoma

Carcinoma, Transitional Cell

Pancreatic Metastatic Cancer

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Clinical Stage 0 Gastric Cancer AJCC v8

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Esophageal Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Clinical Trials

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

FORBES

OPTICAL

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

TRIBE-C

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

TNT Esophagus

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

PREOPANC-3

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

PHITT

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

CLEAR-02

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

ATATcH Alternating Treatment Plans for Advanced Cancer

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

GRACIE

VVSHIP

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

PANGEA

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

PAMELA70

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

LyRICX

Toco-CoR

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer